Review on Assessment and Evaluation of Vitiligo in Primary Care

Vitiligo is an acquired skin disorder characterised by the disappearance of melanocytes, resulting in well-defined white patches that are frequently symmetrically distributed. The lack of melanin pigment makes the lesional skin more sensitive to sunburn. Vitiligo can be cosmetically disfiguring, and it is a stigmatising condition that can lead to serious psychologic problems in daily life. Vitiligo is treated with a variety of topical and systemic medications, phototherapy, laser therapy, and surgical therapy. Corticosteroids, calcineurin inhibitors, and vitamin-D analogues are examples of topical treatment modalities. Phototherapy is a highly effective treatment method. It causes repigmentation in the majority of patients with early and localised disease. Because vitiligo is associated with other autoimmune disorders, a multidisciplinary approach is required. Collaboration and communication between primary care physicians and dermatologists are critical. This review aims to assess role of primary care physicians in assessment and management of vitiligo in primary care settings.